Literature DB >> 27543978

Utility of Examination of Biopsy Tracts in Osteosarcoma Resection Specimens.

Justin M M Cates1.   

Abstract

OBJECTIVES: To determine the utility and necessity of submitting tissue sections from the biopsy tracts of osteosarcoma resection specimens.
METHODS: The prevalence of residual tumor in representative sections of osteosarcoma biopsy tracts was assessed in a series of 97 osteosarcoma resection specimens.
RESULTS: No residual tumor cells were identified in 97 sampled biopsy tracts (0%; 95% confidence interval, 0%-2.5%).
CONCLUSIONS: Pathologists do not need to submit sections of resected biopsy tracts unless there is clinical or gross evidence that would warrant further examination. © American Society for Clinical Pathology, 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Biopsy tract; Local recurrence; Osteosarcoma

Mesh:

Year:  2016        PMID: 27543978     DOI: 10.1093/ajcp/aqw119

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma.

Authors:  Yinsheng Wu; Jiongming You; Feng Li; Feng Wang; Yong Wang
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

2.  MiR-409-3p Inhibits Cell Proliferation and Invasion of Osteosarcoma by Targeting Zinc-Finger E-Box-Binding Homeobox-1.

Authors:  Liang Wu; Yiming Zhang; Zhongyue Huang; Huijie Gu; Kaifeng Zhou; Xiaofan Yin; Jun Xu
Journal:  Front Pharmacol       Date:  2019-02-21       Impact factor: 5.810

3.  The inhibition of microRNA-326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting SMO expression.

Authors:  Jiang-Hu Huang; Yang Xu; Fei-Yue Lin
Journal:  J Cell Mol Med       Date:  2020-08-03       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.